Astellas : News Releases

Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan

20 days ago

Tokyo, 13 June 2025—Mitsubishi Research Institute, Inc. (“MRI”) and Astellas Pharma Inc...

Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2

about 1 month ago

- Agreement grants Astellas exclusive worldwide rights (excluding China’s mainland, Hong Kong...

Posted Notice of Convocation of the 20th Term Annual Shareholders Meeting

about 1 month ago

Shaping the Future with Pompe Patients

about 1 month ago

Astellas and Pfizer’s XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

about 1 month ago

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide)...

Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual Meeting

about 1 month ago

16 abstracts, including two oral presentations, feature new clinical data from Astellas’...

Addressing Global Health Challenges

about 2 months ago

Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme and Performance-linked Stock Delivery Scheme for the Domestic and Global Astellas Group Executives

about 2 months ago

TOKYO, May 15, 2025 – Astellas Pharma Inc. (TSE: 4503, President and...

Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme

about 2 months ago

TOKYO, May 15, 2025– Astellas Pharma Inc. (TSE: 4503, President and CEO...

Cracking the Code to Earlier Bladder Cancer Diagnosis

about 2 months ago

Notice of Nominees for Directors

about 2 months ago

TOKYO, May 7, 2025 – Astellas Pharma Inc. (TSE: 4503, President and...

Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses

about 2 months ago

ARVO and RWC abstracts feature analyses on biomarkers, mechanism of disease,patient experience...